The vacuolar protein sorting 35 (VPS35) is a major component of the retromer recognition core complex which regulates intracellular protein sorting and trafficking.
Mutations in the VPS35 gene are linked to late-onset, autosomal dominant familial Parkinsons disease (PD) , which may involve a link with tau pathology with VPS35 shown to be significantly reduced in two distinct primary tauopathies (Progressive Supra-nuclear Palsy and Picks disease, two distinct primary tauopathies) [1]. There may also be a link between VPS35 and ?-synuclein accumulation, but more work is required to establish the details of the pathiogenic/neuroprotective role of VPS35.
Product Type:
NS Reagents Antibody
Antibody Type:
Polyclonal
Format:
100 µg in 100 µl PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
Storage Temp:
Store at -20?. Avoid freeze / thaw cycles.
Host Animal:
Rabbit
Species Reactivity:
Human, Mouse
Expected Species:
If you would like us to check if this antibody is likely to bind to this protein from a different species please contact us. We are happy to check for you.
If you would like further information regarding the immunogen used in the productiion of this antibody or have a query about whether this antibody will bind to your protein/species please contact us and we can do the analysis for you.
Antibody Isotype:
IgG
Application Details:
WB 1:500-2000. IHC 1:25-100.
Antibody Number:
10109
Category:
Primary Antibodies
Other names:
MEM3, PARK17, Vacuolar protein sorting-associated protein 35, hVPS35, Maternal-embryonic 3, Vesicle protein sorting 35
Research Areas:
Neuroscience
NS Reagents Product Area:
Neuroscience
Molecular Weight:
92 kDa (Intended as a general guide and does not allow for all isoforms and species variations)
Subcellular location:
Cytoplasm, Endosome
Purification:
Affinity purification
References:
[1] Vagnozzi, A.N., Li, J., Chiu, J. et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry (2019) doi:10.1038/s41380-019-0453-x
The vacuolar protein sorting 35 (VPS35) is a major component of the retromer recognition core complex which regulates intracellular protein sorting and trafficking.
Mutations in the VPS35 gene are linked to late-onset, autosomal dominant familial Parkinsons disease (PD) , which may involve a link with tau pathology with VPS35 shown to be significantly reduced in two distinct primary tauopathies (Progressive Supra-nuclear Palsy and Picks disease, two distinct primary tauopathies) [1]. There may also be a link between VPS35 and ?-synuclein accumulation, but more work is required to establish the details of the pathiogenic/neuroprotective role of VPS35.
Product Type:
NS Reagents Antibody
Antibody Type:
Polyclonal
Format:
50 µg in 50 µl PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
Storage Temp:
Store at -20?. Avoid freeze / thaw cycles.
Host Animal:
Rabbit
Species Reactivity:
Human, Mouse
Expected Species:
If you would like us to check if this antibody is likely to bind to this protein from a different species please contact us. We are happy to check for you.
If you would like further information regarding the immunogen used in the productiion of this antibody or have a query about whether this antibody will bind to your protein/species please contact us and we can do the analysis for you.
Antibody Isotype:
IgG
Application Details:
WB 1:500-2000. IHC 1:25-100.
Antibody Number:
10109
Category:
Primary Antibodies
Other names:
MEM3, PARK17, Vacuolar protein sorting-associated protein 35, hVPS35, Maternal-embryonic 3, Vesicle protein sorting 35
Research Areas:
Neuroscience
NS Reagents Product Area:
Neuroscience
Molecular Weight:
92 kDa (Intended as a general guide and does not allow for all isoforms and species variations)
Subcellular location:
Cytoplasm, Endosome
Purification:
Affinity purification
References:
[1] Vagnozzi, A.N., Li, J., Chiu, J. et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry (2019) doi:10.1038/s41380-019-0453-x
The vacuolar protein sorting 35 (VPS35) is a major component of the retromer recognition core complex which regulates intracellular protein sorting and trafficking.
Mutations in the VPS35 gene are linked to late-onset, autosomal dominant familial Parkinsons disease (PD) , which may involve a link with tau pathology with VPS35 shown to be significantly reduced in two distinct primary tauopathies (Progressive Supra-nuclear Palsy and Picks disease, two distinct primary tauopathies) [1]. There may also be a link between VPS35 and ?-synuclein accumulation, but more work is required to establish the details of the pathiogenic/neuroprotective role of VPS35.
Product Type:
NS Reagents Antibody
Antibody Type:
Polyclonal
Format:
100 µg in 100 µl PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Storage Temp:
Store at -20?. Avoid freeze / thaw cycles.
Host Animal:
Rabbit
Species Reactivity:
Human, Mouse, Rat
Expected Species:
Bovine, Dog, Guinea Pig, Golden Hamster, Chicken
Immunogen:
Partial length recombinant human VPS35 from the N-terminal region
If you would like further information regarding the immunogen used in the productiion of this antibody or have a query about whether this antibody will bind to your protein/species please contact us and we can do the analysis for you.
Antibody Isotype:
IgG
Application Details:
WB 1:500-2000.
Antibody Number:
10110
Category:
Primary Antibodies
Other names:
MEM3, PARK17, Vacuolar protein sorting-associated protein 35, hVPS35, Maternal-embryonic 3, Vesicle protein sorting 35
Research Areas:
Neuroscience
NS Reagents Product Area:
Neuroscience
Molecular Weight:
92kDa (Intended as a general guide and does not allow for all isoforms and species variations)
Subcellular location:
Cytoplasm, Endosome
Purification:
Affinity purification
References:
[1] Vagnozzi, A.N., Li, J., Chiu, J. et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry (2019) doi:10.1038/s41380-019-0453-x
The vacuolar protein sorting 35 (VPS35) is a major component of the retromer recognition core complex which regulates intracellular protein sorting and trafficking.
Mutations in the VPS35 gene are linked to late-onset, autosomal dominant familial Parkinsons disease (PD) , which may involve a link with tau pathology with VPS35 shown to be significantly reduced in two distinct primary tauopathies (Progressive Supra-nuclear Palsy and Picks disease, two distinct primary tauopathies) [1]. There may also be a link between VPS35 and ?-synuclein accumulation, but more work is required to establish the details of the pathiogenic/neuroprotective role of VPS35.
Product Type:
NS Reagents Antibody
Antibody Type:
Polyclonal
Format:
50 µg in 50 µl PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Storage Temp:
Store at -20?. Avoid freeze / thaw cycles.
Host Animal:
Rabbit
Species Reactivity:
Human, Mouse, Rat
Expected Species:
Bovine, Dog, Guinea Pig, Golden Hamster, Chicken
Immunogen:
Partial length recombinant human VPS35 from the N-terminal region
If you would like further information regarding the immunogen used in the productiion of this antibody or have a query about whether this antibody will bind to your protein/species please contact us and we can do the analysis for you.
Antibody Isotype:
IgG
Application Details:
WB 1:500-2000.
Antibody Number:
10110
Category:
Primary Antibodies
Other names:
MEM3, PARK17, Vacuolar protein sorting-associated protein 35, hVPS35, Maternal-embryonic 3, Vesicle protein sorting 35
Research Areas:
Neuroscience
NS Reagents Product Area:
Neuroscience
Molecular Weight:
92kDa (Intended as a general guide and does not allow for all isoforms and species variations)
Subcellular location:
Cytoplasm, Endosome
Purification:
Affinity purification
References:
[1] Vagnozzi, A.N., Li, J., Chiu, J. et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry (2019) doi:10.1038/s41380-019-0453-x
Uniprot ID:
Q96QK1
Gene ID:
55737
Gene symbol:
VPS35
Release Date:
Sep-19
Cookies:
X
We use cookies to help personalise and improve your web experience.
By using our website you consent to our use of cookies, some of which may have already been set on your device.
View our Cookie Policy to learn more.
